Tom O'Connor
Managing Associate
Tom is a Managing Associate in our Corporate Finance team, specialising in capital markets transactions.
Awards and Recognition
Biography
Language - English
Jurisdiction - Queensland, Australia
Tom advises clients on a wide range of corporate finance transactions, including public company IPOs and secondary issues — acting for both issuers and banks — as well as private and public company acquisitions and general company law matters. He has experience working with UK, Australian, and international clients across sectors such as mining and exploration, healthcare, life sciences, and technology.
Experience
-
Cavendish
Advised Cavendish in its role as nominated adviser, bookrunner and broker to MHA plc on its £271 million initial public offering on the AIM market of the London Stock Exchange, one of the largest AIM IPOs in recent years.
-
Power Probe plc
Advised Power Probe plc, a leading producer of automotive electrical diagnostic tools, on its £60 million AIM IPO.
-
Strand Hanson and Cavendish
Advised Strand Hanson and Cavendish in their respective roles as nominated adviser and broker to Pathos Communications plc on its £20 million AIM IPO.
-
Augmentum Fintech plc
Advised Main Market listed Augmentum, the UK’s first listed investment fund focussed on fintech, on its £185.7 million takeover by Verdane Fund Manager AB. The transaction was governed by the Takeover Code and effected by a court-sanctioned scheme of arrangement.
-
Novacyt S.A.
Advised long-standing AIM and Euronext Paris-listed diagnostics client Novacyt in relation to its recommended takeover of Yourgene Health plc. The transaction was governed by the Takeover Code and effected by a court-sanctioned scheme of arrangement. Also advised Novacyt on subsequent fundraisings.
-
Base Resources
Advised AIM and ASX listed Australian mineral sands producer Base Resources on the UK aspects of its A$375m public takeover by US-based uranium and critic minerals company, Energy Fuels Inc.
-
The European Smaller Companies Trust plc and Henderson Opportunities Trust plc
Advised The European Smaller Companies Trust plc and Henderson Opportunities Trust plc in connection with their defences against the requisitions by Saba.
-
Liberum Capital
Advised Liberum Capital on its merger with Panmure Gordon to create the UK's largest independent investment bank.
-
Dr. Falk Pharma GmbH
Advised Dr. Falk Pharma, a German multi-national pharmaceutical company, on its successful acquisition of Kynos Therapeutics, a clinical stage biopharmaceutical company spun out from the University of Edinburgh.
NEWS AND INSIGHTS
Stephenson Harwood advises Schroder Real Estate Investment Trust on joint acquisition of Picton
Stephenson Harwood advises Ravensworth (International) Limited on financing of ProService Building Services Marketplace plc
Reframing AIM: Proposed changes to the AIM Rules
Stephenson Harwood advises Augmentum on £185.7 million takeover
Stephenson Harwood advises on two AIM IPOs in a week, signalling renewed momentum for London listings
Stephenson Harwood advises KR1 plc on migration to the Main Market of the LSE
Stephenson Harwood advises Cavendish on MHA plc's London IPO